Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-Gill
Foetal and newborn heart-monitoring best practice can be the difference between life and...
Focus:
-
![Empatica mars wearable]()
Empatica unveils wearable monitor for mission to Mars
-
![alzheimers ipad test]()
Medopad partners with Janssen on digital memory test
-
![fertility tracking devices]()
Cashing in on fertility: should femtech receive more scrutiny?
-
![Abbott and Omada Health to offer personalised diabetes care]()
Abbott and Omada Health to offer personalised diabetes care
-
![]()
IDTechEX Healthcare Sensors Innovation 2019: the future of medical data
-
![Videogames for ADHD]()
Ready player one: booting up the prescription video game
Most Read
- Q&A: the challenge of foetal monitoring with Professor Barrie Hayes-Gill
- Empatica unveils wearable monitor for mission to Mars
- Medopad partners with Janssen on digital memory test
- Cashing in on fertility: should femtech receive more scrutiny?
- IDTechEX Healthcare Sensors Innovation 2019: the future of medical data
Latest Content
Researchers find blood test to identify rare breast cancer mutations
Researchers from Cancer Research UK have found that a blood test could quickly identify rare mutations in patients with advanced breast cancer.
Israeli health tech firms merge to advance AI-powered biomarkers
Israel-based artificial intelligence (AI) startups Beyond Verbal and Healthymize, which both make diagnoses through voice analyses, have merged operations to create an entity, Vocalis Health.
Beta Bionics receives breakthrough designation for blood sugar device
Beta Bionics has secured breakthrough device designation status from the US Food and Drug Administration (FDA) for its iLet Bionic Pancreas System.
Roche obtains CE mark for blood glucose monitoring app
Roche has secured CE mark for its smartphone app that allows users to measure blood glucose level without the need of a meter.
Nihon Kohden introduces new vital signs monitoring device
US-based Nihon Kohden has introduced a new portable vital signs monitoring tool with customisable early warning scoring.
C2N Diagnostics reports positive results for Alzheimer’s blood test
C2N Diagnostics has reported positive results from the clinical study that evaluated APTUS-Aβ blood test’s accuracy in detecting pathology of Alzheimer’s disease in the brain.
Lantheus and CarThera to use microbubbles for glioblastoma treatment
US-based Lantheus Holdings has entered into a strategic partnership with France-based CarThera to expand the use of its microbubbles for treatment of glioblastoma, an aggressive form of brain cancer.
Ceribell introduces EEG monitoring and alerting system
US-based Ceribell has launched an FDA-approved rapid response EEG system that offers around-the-clock bedside EEG monitoring with instantaneous seizure detection and alert.
Inspirata forges technical collaboration with DeePathology
US-based cancer informatics and digital pathology provider Inspirata has entered into a technical partnership with DeePathology on Artificial Intelligence (AI)-based Helicobacter Pylori (H Pylori) pathology testing.
UK researchers launch 90S study for whole genome sequencing
UK researchers have launched a study to assess the potential benefits of whole-genome sequencing in primary health care.
Latest News
Read our magazine
Medical Technology is the essential reading material for decision-makers in the medical device industry, bringing you the latest news and analysis in an exciting, interactive format.
Close
Close
Close
Go Top
